No abstract available
Keywords: ANZSCTS; Australia; COVID-19; CSANZ; Cardiomyopathy; Cardiovascular disease; Myocarditis; Pericarditis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); mRNA vaccine.
MeSH terms
- COVID-19 Vaccines
- COVID-19*
- Cardiomyopathies* / diagnosis
- Cardiomyopathies* / etiology
- Humans
- Myocarditis* / diagnosis
- Myocarditis* / etiology
- Pericarditis* / diagnosis
- Pericarditis* / etiology
- SARS-CoV-2
- Vaccination / adverse effects